Identifying Novel Drug Treatment Options for Pediatric Osteosarcoma

Title

Identifying Novel Drug Treatment Options for Pediatric Osteosarcoma

Files

Download Transcript, Episode 129 (84 KB)

Loading...

Media is loading
 

Document Type

Podcast

Hosts

Michael Smith

Featured Speaker

Tomoo Iwakuma, MD, PhD

Length of Episode

13:17

Description

Osteosarcoma is highly metastatic and drug-resistant cancer. The survival rate for metastatic osteosarcoma remains less than 20 percent for the last 40 years. Tomoo Iwakuma, MD, PhD, is leading research focused on the elucidation of mechanisms underlying osteosarcoma progression and the discovery of novel drugs against this osteosarcoma. His laboratory has identified a lead compound that specifically killed canine and human osteosarcoma cells lacking the activity of the tumor suppressor p53, with minimal impact on non-tumor cells. Join us as we visit with Dr. Iwakuma about this promising research.

Click here to stream the podcast episode.

Publication Date

11-19-2018

Identifying Novel Drug Treatment Options for Pediatric Osteosarcoma

Share

COinS